Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Exercise of Stock Options

26th Jun 2018 11:57

RNS Number : 6223S
Motif Bio PLC
26 June 2018
 

 

Motif Bio plc

("Motif Bio" or the "Company")

 

Exercise of Stock Options 

 

 

Motif Bio plc (AIM/NASDAQ: MTFB), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced that it has received notification from a stock option holder to exercise options representing 125,736 ordinary shares of 1p each ("Ordinary Shares") in the Company at an exercise price of 10.52p per option for total consideration of £13,231.00.

 

Application has been made for the 125,736 new Ordinary Shares to be admitted to trading on AIM ("Admission"), which is expected to occur at 8.00 a.m. on 29 June 2018. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Following Admission, and for the purposes of the Disclosure Guidance and Transparency Rules, the Company's total issued share capital will consist of 296,660,243 Ordinary Shares. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the issued share capital of the Company.

 

For further information please contact:

 

Motif Bio plc

[email protected]

Graham Lumsden (Chief Executive Officer)

Peel Hunt LLP (NOMAD & BROKER)

+ 44 (0)20 7418 8900

Dr Christopher Golden

Oliver Jackson

Northland Capital Partners Limited (BROKER)

+44 (0)203 861 6625

David Hignell/John Howes/Rob Rees

Walbrook PR Ltd. (UK FINANCIAL PR & IR)

+44 (0) 20 7933 8780

Paul McManus/Helen Cresswell/Lianne Cawthorne

 

MC Services AG (EUROPEAN IR)

 

+49 (0)89 210 2280

Raimund Gabriel

[email protected]

Solebury Trout (U.S. IR)

+ 1 (646) 378-2936

Meggie Purcell

[email protected]

Russo Partners (U.S. PR)

+1 (858) 717-2310 or +1 (212) 845 4272

David Schull

[email protected]

Travis Kruse, Ph.D.

[email protected]

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
IOEFFMMTMBATBAP

Related Shares:

MTFB.L
FTSE 100 Latest
Value8,275.66
Change0.00